Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Centrica PLC Board/Management Information 2024

Nov 14, 2024

5292_mang_2024-11-14_14ce4532-91c4-41cd-a53f-f202efeca281.html

Board/Management Information

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

RNS Number : 3313M

Centrica PLC

14 November 2024

14 November 2024

Centrica plc

('Centrica' or 'the Company')

Centrica plc, Appointment of Senior Independent Director

On 25 July 2024, Centrica plc announced that Kevin O'Byrne, currently Senior Independent Director, would succeed Scott Wheway as Chair of the Board from 16 December 2024.

Centrica is pleased to announce the appointment of Jo Harlow as Senior Independent Director, effective from 16 December 2024.  Jo was appointed to the Centrica Board on 1 December 2023 and serves as a member of the Remuneration and Nominations Committees.

Notes

This announcement is made pursuant to UK Listing Rule 6.4.6R.

ENDS

Enquiries:

Investors and Analysts

T: 01753 494900

E: [email protected]

Media

T: 01784 843000

E: [email protected]

Centrica plc is listed on the London Stock Exchange (CNA)

Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654

Legal Entity Identifier number: E26EDV109X6EEPBKVH76

ISIN number: GB00B033F229

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOABIBRTMTTBBRI